bf/NASDAQ:ATXS_icon.jpeg

NASDAQ:ATXS

Astria Therapeutics

  • Stock

USD

Last Close

12.50

25/09 14:39

Market Cap

572.19M

Beta: 0.92

Volume Today

314.69K

Avg: 227.03K

PE Ratio

−7.69

PFCF: −15.76

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
500K
-
cost of revenue
26K
-
gross profit
500K
-
-26K
-
selling and marketing expenses
general and administrative expenses
4.13M
-
6.00M
45.33%
8.63M
43.94%
10.11M
17.14%
8.91M
11.83%
9.33M
4.68%
8.77M
5.98%
11.85M
35.05%
14.81M
25.01%
19.24M
29.93%
25.70M
33.60%
selling general and administrative expenses
4.13M
-
6.00M
45.33%
8.63M
43.94%
10.11M
17.14%
8.91M
11.83%
9.33M
4.68%
8.77M
5.98%
11.85M
35.05%
14.81M
25.01%
19.24M
29.93%
25.70M
33.60%
research and development expenses
13.99M
-
15.69M
12.09%
23.03M
46.82%
25.45M
10.51%
18.68M
26.59%
17.04M
8.78%
18.32M
7.48%
25.59M
39.71%
15.55M
39.23%
34.26M
120.32%
42.13M
22.95%
other expenses
1K
-
3K
200%
7K
133.33%
93K
1,228.57%
32K
65.59%
176K
450%
-50K
128.41%
-101K
102%
-58K
42.57%
-55K
5.17%
15.20M
27,734.55%
cost and expenses
18.12M
-
21.68M
19.66%
31.66M
46.02%
35.56M
12.32%
27.59M
22.40%
26.37M
4.43%
27.09M
2.72%
37.44M
38.20%
30.36M
18.90%
53.50M
76.23%
67.83M
26.78%
operating expenses
18.12M
-
21.68M
19.66%
31.66M
46.02%
35.56M
12.32%
27.59M
22.40%
26.37M
4.43%
27.09M
2.72%
37.44M
38.20%
30.36M
18.90%
53.50M
76.23%
67.83M
26.78%
interest expense
206K
-
978K
374.76%
837K
14.42%
462K
44.80%
100K
78.35%
-1.67M
-
ebitda
-17.80M
-
-21.43M
20.40%
-31.65M
47.70%
-34.83M
10.03%
-26.60M
23.63%
-25.65M
3.56%
-26.27M
2.40%
-37.44M
42.52%
134.26M
458.64%
-53.50M
139.85%
-67.83M
26.78%
operating income
-18.12M
-
-21.68M
19.66%
-31.66M
46.02%
-35.56M
12.32%
-27.09M
23.80%
-26.37M
2.67%
-27.09M
2.72%
-37.44M
38.20%
-194.98M
420.84%
-53.50M
72.56%
-67.83M
26.78%
depreciation and amortization
320K
-
248K
22.50%
202K
18.55%
395K
95.54%
304K
23.04%
119K
60.86%
821K
589.92%
26
100.00%
329.23M
1,266,284,515.38%
total other income expenses net
1K
-
3K
200%
7K
133.33%
93K
1,228.57%
32K
65.59%
176K
450%
795K
351.70%
135K
83.02%
64K
52.59%
1.67M
2,507.81%
-5.06M
403.18%
income before tax
-18.12M
-
-21.88M
20.79%
-32.63M
49.10%
-36.06M
10.51%
-27.36M
24.12%
-25.87M
5.46%
-26.29M
1.64%
-37.30M
41.86%
-194.91M
422.55%
-51.83M
73.41%
-72.89M
40.62%
income tax expense
209K
-
783K
274.64%
930K
18.77%
494K
46.88%
601K
21.66%
-50K
108.32%
-236K
372%
-164.74M
69,704.66%
-1.67M
98.99%
net income
-18.12M
-
-21.88M
20.79%
-32.63M
49.10%
-36.06M
10.51%
-27.36M
24.12%
-25.87M
5.46%
-26.24M
1.44%
-37.06M
41.23%
-30.17M
18.59%
-50.16M
66.26%
-72.89M
45.30%
weighted average shs out
144.42K
-
144.42K
0%
134.03K
7.19%
270.50K
101.82%
361.36K
33.59%
842.47K
133.14%
1.87M
121.55%
3.06M
63.87%
8.93M
191.81%
14.62M
63.81%
30.12M
106.03%
weighted average shs out dil
144.42K
-
144.42K
0%
134.03K
7.19%
270.50K
101.82%
361.36K
33.59%
842.47K
133.14%
1.87M
121.55%
3.06M
63.87%
8.93M
191.81%
14.62M
63.81%
30.12M
106.03%
eps
-125.45
-
-151.53
20.79%
-243.45
60.66%
-133.31
45.24%
-75.73
43.19%
-30.71
59.45%
-14.06
54.22%
-12.12
13.80%
-3.38
72.11%
-3.43
1.48%
-2.42
29.45%
epsdiluted
-125.45
-
-151.53
20.79%
-243.45
60.66%
-133.31
45.24%
-75.73
43.19%
-30.71
59.45%
-14.06
54.22%
-12.12
13.80%
-3.38
72.11%
-3.43
1.48%
-2.42
29.45%

All numbers in USD (except ratios and percentages)